PUBLISHER: Polaris Market Research | PRODUCT CODE: 1786905
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1786905
U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Industry Analysis Report By Type [Transurethral Resection of Prostate (TURP), Prostatic Urethral Lift], By End User- Market Forecast, 2025-2034
The U.S. benign prostatic hyperplasia surgical treatment market size is expected to reach USD 1,232.65 million by 2034, according to a new study by Polaris Market Research. The report "U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Share, Size, Trends, Industry Analysis Report By Type [Transurethral Resection of Prostate (TURP), Prostatic Urethral Lift], By End User; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Benign prostatic hyperplasia surgical treatment refers to clinically guided procedures aimed at relieving urinary symptoms associated with prostate gland enlargement in aging men. The growing preference for outpatient and minimally invasive surgery approaches, which offer shorter hospital stays and quicker recovery times, is driving market growth. This shift is driven by growing patient awareness, payer support for cost-effective interventions, and the healthcare system's focus on enhancing procedural efficiency. As a result, there is a growing acceptance of advanced surgical techniques that balance clinical outcomes and patient comfort.
The rapid integration of advanced technologies drives the U.S. BPH surgical treatment market, supporting precision and consistency in surgical care. Innovations in urology tools, real-time imaging, surgical robot, and energy-based devices are streamlining treatment workflows and improving patient outcomes. These technological advancements are encouraging the adoption of evidence-based practices and personalized care strategies, reinforcing the market's shift toward high-value, outcome-oriented healthcare delivery.
U.S. Benign Prostatic Hyperplasia Surgical Treatment Market Report Highlights
In terms of type, the transurethral resection of the prostate (TURP) segment led the U.S. benign prostatic hyperplasia surgical treatment market in 2024, owing to its proven clinical effectiveness and established role as the standard treatment for BPH.
Based on end user, the ambulatory surgery centers (ASCs) segment is expected to achieve the highest CAGR during the forecast period, driven by increasing demand for outpatient procedures and cost-efficient healthcare delivery.
A few market players include Boston Scientific Corporation; Cleveland Clinic; Cook Medical; Eli Lilly and Company; Medifocus, Inc.; Medtronic; PROCEPT BioRobotics Corporation; Teleflex Incorporated; The Johns Hopkins Hospital; and Viatris Inc.
Polaris Market Research has U.S. Benign Prostatic Hyperplasia Surgical Treatment Market segmented the market report on the basis of type and end user:
By Type Outlook (Revenue, USD Million, 2020-2034)
Transurethral Resection of the Prostate (TURP)
Prostatic Urethral Lift
Water Vapor Therapy
Laser Therapy
Aquablation Therapy
Transurethral Microwave Thermotherapy (TUMT)
Others
By End User Outlook (Revenue, USD Million, 2020-2034)
Hospitals
Ambulatory Surgery Centers and Clinics
Homecare Settings
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. US Benign Prostatic Hyperplasia Surgical Treatment Market Insights
- 4.1. US Benign Prostatic Hyperplasia Surgical Treatment Market - Market Snapshot
- 4.2. US Benign Prostatic Hyperplasia Surgical Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Demand From Aging Male Population
- 4.2.1.2. Advancements in Urology Technology
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Increasing Regulatory Burden and Compliance Costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. US Benign Prostatic Hyperplasia Surgical Treatment Market Trends
- 4.6. Value Chain Analysis
5. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Million)
- 5.3. Transurethral Resection of the Prostate (TURP)
- 5.3.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Resection of the Prostate (TURP), by Region, 2020-2034 (USD Million)
- 5.4. Prostatic Urethral Lift
- 5.4.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Urethral Lift, by Region, 2020-2034 (USD Million)
- 5.5. Water Vapor Therapy
- 5.5.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Water Vapor Therapy, by Region, 2020-2034 (USD Million)
- 5.6. Laser Therapy
- 5.6.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Laser Therapy, by Region, 2020-2034 (USD Million)
- 5.7. Aquablation Therapy
- 5.7.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Aquablation Therapy, by Region, 2020-2034 (USD Million)
- 5.8. Transurethral Microwave Thermotherapy (TUMT)
- 5.8.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Microwave Thermotherapy (TUMT), by Region, 2020-2034 (USD Million)
- 5.9. Others
- 5.9.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Others, by Region, 2020-2034 (USD Million)
6. US Benign Prostatic Hyperplasia Surgical Treatment Market, by End User
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Million)
- 6.3. Hospitals
- 6.3.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Hospitals, by Region, 2020-2034 (USD Million)
- 6.4. Ambulatory Surgery Centers and Clinics
- 6.4.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Technology, by Region, 2020-2034 (USD Million)
- 6.5. Homecare Settings
- 6.5.1. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Technology, by Region, 2020-2034 (USD Million)
7. Competitive Landscape
- 7.1. Expansion and Acquisition Analysis
- 7.1.1. Expansion
- 7.1.2. Acquisitions
- 7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
- 8.1. Boston Scientific Corporation
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Recent Development
- 8.2. Cleveland Clinic
- 8.2.1. Company Overview
- 8.2.2. Financial Performance
- 8.2.3. Product Benchmarking
- 8.2.4. Recent Development
- 8.3. Cook Medical
- 8.3.1. Company Overview
- 8.3.2. Financial Performance
- 8.3.3. Product Benchmarking
- 8.3.4. Recent Development
- 8.4. Eli Lilly and Company
- 8.4.1. Company Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.4. Recent Development
- 8.5. Medifocus, Inc.
- 8.5.1. Company Overview
- 8.5.2. Financial Performance
- 8.5.3. Product Benchmarking
- 8.5.4. Recent Development
- 8.6. Medtronic
- 8.6.1. Company Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.4. Recent Development
- 8.7. PROCEPT BioRobotics Corporation
- 8.7.1. Company Overview
- 8.7.2. Financial Performance
- 8.7.3. Product Benchmarking
- 8.7.4. Recent Development
- 8.8. Teleflex Incorporated
- 8.8.1. Company Overview
- 8.8.2. Financial Performance
- 8.8.3. Product Benchmarking
- 8.8.4. Recent Development
- 8.9. The Johns Hopkins Hospital
- 8.9.1. Company Overview
- 8.9.2. Financial Performance
- 8.9.3. Product Benchmarking
- 8.9.4. Recent Development
- 8.10. Viatris Inc.
- 8.10.1. Company Overview
- 8.10.2. Financial Performance
- 8.10.3. Product Benchmarking
- 8.10.4. Recent Development
List of Tables:
- Table 1 US Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Million)
- Table 2 US Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Million)
List of Figures:
- Figure 1. US Benign Prostatic Hyperplasia Surgical Treatment Market, 2020-2034 (USD Million)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Type
- Figure 7. US Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2024 & 2034 (USD Million)
- Figure 8. Market by End User
- Figure 9. US Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2024 & 2034 (USD Million)
